CANADA-ISRAEL INDUSTRIAL R&D FOUNDATION FUNDS CARDIOCOMM SOLUTIONS TO FAST-TRACK WEARABLE MEDICAL DEVICE INTEGRATION

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a leading global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG“) software solutions, today announced it has been awarded a $567,079 grant from the Canada-Israel Industrial Research and Development Foundation (“CIIRDF“) to enable R&D collaborations with HealthWatch Technologies Ltd. (“HealthWatch“) of Israel. … Read more

CardioComm Solutions Reports a Profitable Start to 2017 and Net Positive Cash Flow over the Last Four Fiscal Quarters

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, released its first quarter 2017 financials and confirms its strongest fiscal performance continues with a profitable start to 2017. The Company’s management continues to maintain control over expenses while … Read more

CARDIOCOMM SOLUTIONS ISSUES STOCK OPTIONS

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram software solutions, today announced that it has granted an aggregate of 1,000,000 stock options to the directors of the Company as remuneration for their contributions to the Company as members of the board … Read more

2016 YEAR END FINANCIALS CONFIRM CARDIOCOMM SOLUTIONS IS AT AN INFLECTION POINT AS A RECOGNIZED MEDICAL SOLUTIONS PROVIDER

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today released its 2016 year end financials and confirms its strongest fiscal performance yet. The Company’s management has worked to successfully reduce expenses while maintaining overall revenue generation through … Read more

CARDIOCOMM SOLUTIONS AND HEALTHWATCH TECHNOLOGIES TO INTRODUCE THE FIRST FDA CLEARED, 12 LEAD ECG SHIRT-BASED REMOTE ECG MANAGEMENT & ANALYSIS SOLUTION

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a consistent, global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced it has entered into a development, distribution and co-marketing agreement with Israel-based HealthWatch Technologies Ltd. (“HealthWatch”) for the development, sales and marketing of a smart shirt based … Read more

CARESPAN TO INTEGRATE CARDIOCOMM SOLUTIONS’ ELECTROCARDIOGRAM TOOLSET INTO ITS VIRTUAL CLINIC

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced a partnership with CareSpan USA Inc., a leading provider of digital healthcare delivery systems, entered into on April 21, 2017. Under the agreement the parties have agreed to … Read more

CARDIOCOMM SOLUTIONS CLOSES EQUITY FINANCING

TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has closed its previously announced equity financing for gross proceeds of $76,000. The equity financing was conducted to allow parties who were not able to participate in the Company’s December 2016 private placement to invest in the Company. The proceeds … Read more

CARDIOCOMM SOLUTIONS ANNOUNCES FOLLOW UP PRIVATE PLACEMENT RAISE

Financing allows investment by parties not able to participate in December, 2016 equity raise TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it is conducting a non-brokered private placement equity financing under which it intends to issue up to 3,000,000 units at a price of $0.05 per unit for … Read more

CARDIOCOMM SOLUTIONS CONFIRMS CLOSING $1.1 MILLION IN EQUITY AND DEBT FINANCING

Private placement remains open while the Company readies efforts for new initiatives in 2017 TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has closed its previously announced debt financing of $600,000 and the first tranche of its previously announced equity financing for gross proceeds of $500,000. Under the … Read more

CARDIOCOMM SOLUTIONS TO CLOSE THE FIRST TRANCHE OF ITS ANNOUNCED PRIVATE PLACEMENT AND CONFIRMS A DEBT FINANCING OFFERING

$1.169M in debt and equity fundraising and debt reduction is the foundation for continued growth in 2017 TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that the Company is: Conducting a non-brokered debt financing under which it intends to raise up to $600,000; Intending to close the first $500,000 tranche … Read more